Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

NCT04156685 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: Part A, Reference (D635 10/500mg, Astrazeneca)
DRUG: Part A, Reference (D635 10/500mg, Astrazeneca)
DRUG: Part B, Reference (D635 10/500mg, Astrazeneca)
DRUG: Part B, Reference (D635 10/500mg, Astrazeneca)

Sponsor

Chong Kun Dang Pharmaceutical